Literature DB >> 14578444

Anti-TNF treatment in secondary amyloidosis.

V Ortiz-Santamaria, M Valls-Roc, M Sanmartí, A Olive.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14578444     DOI： 10.1093/rheumatology/keg361

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis.

Authors:  Senol Kobak
Journal:  Rheumatol Int       Date:  2010-03-26       Impact factor: 2.631

2.  Etanercept treatment in patients with rheumatoid arthritis on dialysis.

Authors:  Tadashi Nakamura; Syu-Ichi Higashi; Kunihiko Tomoda; Michishi Tsukano; Kenzi Arizono; Takamichi Nakamura
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

Review 3.  A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review.

Authors:  Ioanna Saougou; Charalampos Papagoras; Theodora E Markatseli; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Clin Rheumatol       Date:  2010-05-21       Impact factor: 2.980

4.  Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi; Serdal Ugurlu; Aycan Gokturk; Koray Tascilar; Huri Ozdogan
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

5.  Serum amyloid a as a useful indicator of disease activity in patients with ankylosing spondylitis.

Authors:  Sang Youn Jung; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.